Publicacions (41) Publicacions en què ha participat algun/a investigador/a

2017

  1. A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice

    Neuropsychopharmacology, Vol. 42, Núm. 2, pp. 524-539

  2. A combined PD-1/C5a blockade synergistically protects against lung cancer growth and metastasis

    Cancer Discovery, Vol. 7, Núm. 7, pp. 694-703

  3. AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy

    Molecular Therapy, Vol. 25, Núm. 12, pp. 2727-2742

  4. ALK and ROS1 testing on lung cancer cytologic samples: Perspectives

    Cancer Cytopathology, Vol. 125, Núm. 11, pp. 817-830

  5. Adeno-associated viral vectors serotype 8 for cell-specific delivery of therapeutic genes in the central nervous system

    Frontiers in Neuroanatomy, Vol. 11

  6. All for one and FOSL1 for all: FOSL1 at the crossroads of lung and pancreatic cancer driven by mutant KRAS

    Molecular and Cellular Oncology, Vol. 4, Núm. 3

  7. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

    Nature Communications, Vol. 8

  8. Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors

    Frontiers in Pharmacology, Vol. 8, Núm. OCT

  9. Brain renin-angiotensin system and microglial polarization: Implications for aging and neurodegeneration

    Frontiers in Aging Neuroscience, Vol. 9, Núm. MAY

  10. Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens

    Cancer Cytopathology, Vol. 125, Núm. 8, pp. 615-626

  11. Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer

    Oncotarget, Vol. 8, Núm. 62, pp. 105196-105210

  12. Development of biological tools to assess the role of TMPRSS4 and identification of novel tumor types with high expression of this prometastatic protein

    Histology and Histopathology, Vol. 32, Núm. 9, pp. 929-940

  13. Dual modulation of MCL-1 and mTOR determines the response to sunitinib

    Journal of Clinical Investigation, Vol. 127, Núm. 1, pp. 153-168

  14. E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 39, pp. E8274-E8283

  15. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

    Journal of Hematology and Oncology, Vol. 10, Núm. 1, pp. 1-12

  16. Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD65-induced immune response

    Diabetologia, Vol. 60, Núm. 7, pp. 1276-1283

  17. Erratum: The disruption of mitochondrial axonal transport is an early event in neuroinflammation. [J Neuroinflammation., 12, 1, (2015)(152)] DOI: 10.1186/s12974-015-0375-8

    Journal of Neuroinflammation

  18. Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells

    Brain Structure and Function, Vol. 222, Núm. 6, pp. 2559-2571

  19. Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition

    Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3203-3213

  20. Immune mediated colitis caused by lung cancer treatment with atezolizumab

    Revista Espanola de Enfermedades Digestivas